Total cancer care moffit cancer center
GO
 

Jimmy J. Caudell, PhD, MD

Where You Are:

Jimmy J. Caudell, PhD, MD

Radiation Therapy

 
 

BOARD CERTIFICATION:
          •  Radiation Oncology

FELLOWSHIP:

RESIDENCY:
          •  University of Alabama, Birmingham - Radiation Oncology
          •  University of Alabama, Birmingham - Radiation Oncology

MEDICAL SCHOOL:
          •  University of Texas Houston School of Medicine - MD

  • Dragovic AF, Caudell JJ, Spencer SA, Carroll WR, Nabell LA, Bonner JA. Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Head Neck. 2013 Mar;35(3):381-387. Pubmedid: 22407986.

  • Schaner PE, Caudell JJ, De Los Santos JF, Spencer SA, Shen S, Kim RY. Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer: the university of alabama at birmingham experience. Int J Gynecol Cancer. 2013 Mar;23(3):559-566. Pubmedid: 23385283.

  • Batth SS, Caudell JJ, Chen AM. Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer. Head Neck. 2013 Mar. Pubmedid: 23508721.

  • May JT, Rao N, Sabater RD, Boutrid H, Caudell JJ, Merchant F, Han G, Padhya TA, McCaffrey JC, Tanvetyanon T, Deconti R, Kish J, McCaffrey TV, Trotti A. Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma. Head Neck. 2013 Mar. Pubmedid: 23468387.

  • Locher JL, Bonner JA, Carroll WR, Caudell JJ, Allison JJ, Kilgore ML, Ritchie CS, Tajeu GS, Yuan Y, Roth DL. Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: A consideration of the significance of social support and practice variation. Laryngoscope. 2013 Feb. Pubmedid: 23401235.

  • Caudell JJ, Hamilton RD, Otto KJ, Jennelle RL, Pitman KT, Vijayakumar S. Induction Docetaxel, Cisplatin, and 5-Fluorouracil Precludes Definitive Chemoradiotherapy in a Substantial Proportion of Patients With Head and Neck Cancer in a Low Socioeconomic Status Population. Am J Clin Oncol. 2012 Dec. Pubmedid: 23275276.

  • Locher JL, Bonner JA, Carroll WR, Caudell JJ, Kilgore ML, Ritchie CS, Roth DL, Tajeu GS, Yuan Y, Allison JJ. Gastrostomy tube placement and use in patients with head and neck cancer. Head Neck. 2012 Mar;34(3):422-428. Pubmedid: 21604317.

  • Wagner MM, Cur? JK, Caudell JJ, Spencer SA, Nabell LM, Carroll WR, Bonner JA. Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies. Radiat Oncol. 2012;7:219. Pubmedid: 23256610.

  • Monaghan MT, Bonner JA, Schaner PE, Caudell JJ. Dosimetric impact of target definitions on normal structures in head and neck cancer. Head Neck Oncol. 2011 Dec;3:34. Pubmedid: 21834975. Pmcid: PMC3169501.

  • Caudell JJ, Carroll WR, Spencer SA, Bonner JA. Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. Cancer. 2011 Oct;117(19):4447-4451. Pubmedid: 21437891.

  • Locher JL, Bonner JA, Carroll WR, Caudell JJ, Keith JN, Kilgore ML, Ritchie CS, Roth DL, Tajeu GS, Allison JJ. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr. 2011 May;35(3):365-374. Pubmedid: 21527598.

  • Caudell JJ, Locher JL, Bonner JA. Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011 Mar;137(3):282-285. Pubmedid: 21422314.

  • Dragovic AF, Bonner JA, Spencer SA, Nabell LM, Carroll WR, Caudell JJ. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer. Head Neck. 2010 Dec. Pubmedid: 21154619.

  • Caudell JJ, Burnett OL, Schaner PE, Bonner JA, Duan J. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jun;77(2):462-467. Pubmedid: 19577862.

  • Sawrie SM, Fiveash JB, Caudell JJ. Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity. Cancer Control. 2010 Apr;17(2):111-119. Pubmedid: 20404794.

  • Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2010 Feb;76(2):403-409. Pubmedid: 19467801.

  • Caudell JJ, Meredith RF, Spencer SA, Keene KS, Dobelbower MC, Bonner JA. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jan;76(1):164-168. Pubmedid: 19386438.

  • Iseli TA, Iseli CE, Rosenthal EL, Caudell JJ, Spencer SA, Magnuson JS, Smith AN, Carroll WR. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1158-1164. Pubmedid: 19917931.

  • Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, Magnuson JS, Spencer SA, Bonner JA. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009 Feb;73(2):410-415. Pubmedid: 18635320.

  • Caudell JJ, Sawrie SM, Spencer SA, Desmond RA, Carroll WR, Peters GE, Nabell LM, Meredith RF, Bonner JA. Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys. 2008 Jul;71(3):676-681. Pubmedid: 18355979.

  • Caudell JJ, De Los Santos JF, Keene KS, Fiveash JB, Wang W, Carlisle JD, Popple R. A dosimetric comparison of electronic compensation, conventional intensity modulated radiotherapy, and tomotherapy in patients with early-stage carcinoma of the left breast. Int J Radiat Oncol Biol Phys. 2007 Aug;68(5):1505-1511. Pubmedid: 17674981.

  • Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):167-170. Pubmedid: 15894930.

  • Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, Marco RA, El-Naggar AK, Benjamin RS, Yasko AW. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep;57(1):158-165. Pubmedid: 12909228.

  • Yin Z, Babaian RJ, Troncoso P, Strom SS, Spitz MR, Caudell JJ, Stein JD, Kagan J. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene. 2001 Apr;20(18):2273-2280. Pubmedid: 11402322.

  • Caudell EG, Caudell JJ, Tang CH, Yu TK, Frederick MJ, Grimm EA. Characterization of human copine III as a phosphoprotein with associated kinase activity. Biochemistry. 2000 Oct;39(42):13034-13043. Pubmedid: 11041869.

Clinical internests include treatment of head and neck cancer with radiotherapy.

 
TOOLS:   Font Size
 |  Site Map  |  Privacy Policy  |  Terms and Conditions  |  Staff Login